Biopharma

Abstract The aim of this study was to assess to what extent a simulated trehalose monolayer can predict the minimum...

August, 2026 Commercialization follows strong interest from pharmaceutical developers worldwide Ashland Inc. (NYSE: ASH), has announced the launch of permexa™...

Abstract Pediatric maintenance therapy for acute lymphoblastic leukemia requires prolonged daily administration of 6-mercaptopurine (6-MP), a drug characterized by a...

Abstract Polymers offer a promising alternative to established lipid nanoparticles for therapeutic RNA delivery. Here, we introduce alkyl-chain-quaternized poly(vinylpyrrolidone-co-4-vinylpyridine) copolymers...

Viatel™ polymers are used in the fabrication of degradable medical devices and tissue engineering solutions. medical devices and tissue engineering...

Lille, France, September 30, 2026 Roquette will showcase its end-to-end portfolio of pharmaceutical excipients, drug delivery solutions and leading technical...

Abstract The most relevant challenge concerning the semi-solid extrusion 3D printing (SSE) pharmaceutical application is the development of versatile inks...

The promise of oral biologics continues to drive innovation across the pharmaceutical industry.  While permeation enhancement remains critical for successful...

New formulation strategies are beginning to yield clinically and commercially viable oral biological therapies, according to a Lonza whitepaper published...

Abstract The oral delivery of biologics such as oligonucleotides may be enabled by the use of a chemical permeation enhancer...